Tags: SOCMA Member News


Pilot Chemical Adds EPA Emerging Viral Pathogen Claim to Eight Products

Pilot Chemical Corp. is pleased to announce that through its subsidiary Mason Chemical Company, it has received EPA acceptance to add an emerging viral pathogen claim to the labels of eight products from the company’s EPA-registered quaternary ammonium compound and active ingredient line, under its Maquat® and Maguard® brands.

October 1, 2020

CJB and National FFA Launch a Cooperative Venture

The CJB companies (CJB Industries, Inc. and CJB Applied Technologies, LLC) have announced a cooperative venture with National FFA to benefit the companies who support National FFA as well as the National FFA itself.

September 30, 2020



Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen’s COVID-19 Therapeutic Candidate Lenzilumab

Humanigen, a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper response called ‘cytokine storm,’ and Lonza today announced a strategic collaboration to expand the manufacturing capacity for lenzilumab, currently in Phase 3 clinical trials for COVID-19, in advance of potential Emergency Use Authorization in 2020 and subsequent commercialization.

September 16, 2020